Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family

Vaccine. 2021 Jun 16;39(27):3560-3564. doi: 10.1016/j.vaccine.2021.05.023. Epub 2021 May 22.

Abstract

Adenoviruses cause economically important diseases in vertebrates. Effective vaccines against adenoviral diseases are currently lacking. Here, we report a highly conserved epitopic region on hexon proteins of adenoviruses that generate a strong immune response when used as a virus-like-particle (VLP) vaccine, produced by inserting the epitopic region into the core protein of hepatitis B virus. For evaluation of its protective efficacy, the epitopic region from a representative adenovirus, fowl adenovirus serotype 4 (FAdV-4), was tested as a VLP vaccine which conferred 90% protection against challenge with a virulent FAdV-4 isolate in chickens. Importantly, such a high level of protection is not achieved when the epitopic region is employed as a part of a subunit vaccine. As the sequence and the structure of the epitopic region are highly conserved in hexon proteins of adenoviruses, the epitopic region could be employed as a promising VLP vaccine candidate against adenoviral diseases, in general.

Keywords: Adenoviridae family; Epitope; Hexon; Hydropericardium syndrome; Vaccine; Virus-like particle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae Infections* / prevention & control
  • Adenoviridae Infections* / veterinary
  • Adenovirus Vaccines*
  • Animals
  • Capsid Proteins / genetics
  • Chickens
  • Epitopes
  • Poultry Diseases* / prevention & control

Substances

  • Adenovirus Vaccines
  • Capsid Proteins
  • Epitopes